 Maria Cavasin
Concepts (256)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ventricular Remodeling | 13 | 2021 | 226 | 1.420 |
Why?
| | Histone Deacetylases | 7 | 2018 | 195 | 0.950 |
Why?
| | Myocardial Infarction | 8 | 2022 | 927 | 0.820 |
Why?
| | Oligopeptides | 5 | 2010 | 236 | 0.800 |
Why?
| | Hypertrophy, Right Ventricular | 3 | 2021 | 141 | 0.770 |
Why?
| | Histone Deacetylase Inhibitors | 6 | 2021 | 198 | 0.690 |
Why?
| | Myocardium | 14 | 2022 | 913 | 0.680 |
Why?
| | Hypertension, Pulmonary | 5 | 2021 | 1729 | 0.570 |
Why?
| | Phosphodiesterase 5 Inhibitors | 1 | 2014 | 36 | 0.470 |
Why?
| | Receptors, Endothelin | 1 | 2014 | 49 | 0.470 |
Why?
| | Angiotensin II | 7 | 2021 | 87 | 0.460 |
Why?
| | Rats | 17 | 2022 | 4958 | 0.450 |
Why?
| | Rats, Sprague-Dawley | 11 | 2019 | 2218 | 0.430 |
Why?
| | Heart | 4 | 2007 | 612 | 0.420 |
Why?
| | Myocytes, Cardiac | 9 | 2022 | 449 | 0.400 |
Why?
| | Cell Proliferation | 4 | 2021 | 2187 | 0.380 |
Why?
| | Cardiomegaly | 4 | 2016 | 157 | 0.380 |
Why?
| | Blood Pressure | 10 | 2022 | 1538 | 0.380 |
Why?
| | Kidney | 5 | 2022 | 1188 | 0.380 |
Why?
| | Testosterone | 2 | 2005 | 343 | 0.370 |
Why?
| | Muscle, Smooth, Vascular | 2 | 2021 | 411 | 0.360 |
Why?
| | Heart Ventricles | 6 | 2021 | 712 | 0.360 |
Why?
| | Endothelin Receptor Antagonists | 1 | 2010 | 58 | 0.350 |
Why?
| | Animals | 35 | 2022 | 31708 | 0.340 |
Why?
| | Thymosin | 2 | 2006 | 5 | 0.320 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 4 | 2004 | 179 | 0.310 |
Why?
| | Liver Cirrhosis | 1 | 2010 | 227 | 0.310 |
Why?
| | Hemodynamics | 3 | 2018 | 1012 | 0.300 |
Why?
| | Heart Failure | 6 | 2022 | 1945 | 0.290 |
Why?
| | Vascular Remodeling | 2 | 2021 | 153 | 0.290 |
Why?
| | Serine Endopeptidases | 2 | 2007 | 102 | 0.290 |
Why?
| | Fibrosis | 7 | 2022 | 453 | 0.280 |
Why?
| | Mice, Inbred C57BL | 10 | 2022 | 4694 | 0.280 |
Why?
| | Glomerulosclerosis, Focal Segmental | 1 | 2007 | 29 | 0.280 |
Why?
| | Mice | 21 | 2022 | 14871 | 0.260 |
Why?
| | Transcription Factors | 3 | 2019 | 1528 | 0.250 |
Why?
| | Disease Models, Animal | 11 | 2022 | 3535 | 0.240 |
Why?
| | Kidney Cortex | 1 | 2004 | 23 | 0.230 |
Why?
| | Ventricular Dysfunction, Left | 2 | 2018 | 358 | 0.230 |
Why?
| | Antihypertensive Agents | 3 | 2010 | 429 | 0.220 |
Why?
| | Pulmonary Artery | 2 | 2021 | 1016 | 0.220 |
Why?
| | Collagen | 7 | 2007 | 415 | 0.200 |
Why?
| | Liver | 1 | 2010 | 1637 | 0.200 |
Why?
| | Myofibrils | 1 | 2022 | 46 | 0.200 |
Why?
| | Sarcomeres | 1 | 2022 | 90 | 0.190 |
Why?
| | Ramipril | 2 | 2001 | 4 | 0.190 |
Why?
| | Myocytes, Smooth Muscle | 2 | 2021 | 236 | 0.190 |
Why?
| | Gonadal Steroid Hormones | 1 | 2003 | 124 | 0.190 |
Why?
| | Tetrazoles | 2 | 2001 | 32 | 0.190 |
Why?
| | Dual-Specificity Phosphatases | 1 | 2021 | 10 | 0.190 |
Why?
| | Heart Murmurs | 1 | 2021 | 11 | 0.180 |
Why?
| | Angiotensin I | 1 | 2000 | 5 | 0.180 |
Why?
| | Imidazoles | 2 | 2001 | 208 | 0.180 |
Why?
| | Extracellular Matrix | 2 | 2021 | 436 | 0.170 |
Why?
| | Cells, Cultured | 6 | 2022 | 3886 | 0.170 |
Why?
| | Male | 23 | 2022 | 55606 | 0.170 |
Why?
| | Estradiol | 1 | 2003 | 455 | 0.170 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2022 | 498 | 0.170 |
Why?
| | Reperfusion Injury | 1 | 2022 | 255 | 0.160 |
Why?
| | Regional Blood Flow | 2 | 2012 | 424 | 0.160 |
Why?
| | Hypertension | 4 | 2011 | 1056 | 0.160 |
Why?
| | Cardiomyopathies | 1 | 2022 | 298 | 0.160 |
Why?
| | Thermogenesis | 1 | 2018 | 37 | 0.150 |
Why?
| | Adipose Tissue, Brown | 1 | 2018 | 43 | 0.150 |
Why?
| | Myofibroblasts | 1 | 2019 | 116 | 0.150 |
Why?
| | Drug Discovery | 2 | 2016 | 123 | 0.150 |
Why?
| | High-Throughput Screening Assays | 2 | 2016 | 123 | 0.140 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2019 | 388 | 0.140 |
Why?
| | Tryptophan Hydroxylase | 1 | 2016 | 52 | 0.130 |
Why?
| | Hypoxia | 2 | 2013 | 958 | 0.130 |
Why?
| | Fatty Liver | 1 | 2018 | 211 | 0.130 |
Why?
| | Enzyme Inhibitors | 3 | 2016 | 750 | 0.130 |
Why?
| | Chromatin | 1 | 2019 | 428 | 0.130 |
Why?
| | Acute Kidney Injury | 1 | 2022 | 638 | 0.120 |
Why?
| | Ventricular Function, Right | 1 | 2017 | 250 | 0.120 |
Why?
| | Nuclear Proteins | 1 | 2019 | 591 | 0.120 |
Why?
| | Protease Inhibitors | 2 | 2007 | 97 | 0.120 |
Why?
| | Fibroblasts | 2 | 2022 | 838 | 0.120 |
Why?
| | Transcription Factor CHOP | 1 | 2014 | 28 | 0.120 |
Why?
| | Captopril | 2 | 2004 | 10 | 0.120 |
Why?
| | Matrix Metalloproteinase 2 | 2 | 2004 | 57 | 0.110 |
Why?
| | Ovariectomy | 2 | 2005 | 116 | 0.110 |
Why?
| | Mice, Knockout | 6 | 2021 | 2570 | 0.110 |
Why?
| | Matrix Metalloproteinase 9 | 2 | 2004 | 119 | 0.110 |
Why?
| | Muscular Atrophy | 1 | 2014 | 78 | 0.110 |
Why?
| | Adenylate Kinase | 1 | 2013 | 26 | 0.110 |
Why?
| | Histone Deacetylase 6 | 3 | 2022 | 19 | 0.100 |
Why?
| | Endoplasmic Reticulum | 1 | 2014 | 234 | 0.100 |
Why?
| | Calcinosis | 1 | 2014 | 242 | 0.100 |
Why?
| | Vascular Diseases | 1 | 2014 | 230 | 0.090 |
Why?
| | Benzamides | 1 | 2012 | 169 | 0.090 |
Why?
| | Heart Defects, Congenital | 1 | 2017 | 671 | 0.090 |
Why?
| | Portal Pressure | 1 | 2010 | 4 | 0.090 |
Why?
| | Hepatic Stellate Cells | 1 | 2010 | 10 | 0.090 |
Why?
| | Connectin | 2 | 2022 | 30 | 0.090 |
Why?
| | Receptor, Endothelin B | 1 | 2010 | 51 | 0.090 |
Why?
| | Receptor, Endothelin A | 1 | 2010 | 60 | 0.090 |
Why?
| | Gene Expression Regulation | 3 | 2018 | 2320 | 0.090 |
Why?
| | RNA-Binding Proteins | 1 | 2013 | 345 | 0.090 |
Why?
| | Hypertension, Portal | 1 | 2010 | 61 | 0.080 |
Why?
| | Carrier Proteins | 1 | 2013 | 695 | 0.080 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2014 | 486 | 0.080 |
Why?
| | Piperidines | 1 | 2010 | 160 | 0.080 |
Why?
| | Pyrimidines | 1 | 2012 | 376 | 0.080 |
Why?
| | Sex Factors | 2 | 2022 | 1715 | 0.080 |
Why?
| | Endothelin-1 | 1 | 2010 | 168 | 0.080 |
Why?
| | Nephrosclerosis | 1 | 2008 | 6 | 0.080 |
Why?
| | Peptides, Cyclic | 1 | 2010 | 253 | 0.080 |
Why?
| | Pyridines | 1 | 2012 | 425 | 0.080 |
Why?
| | Macrophages | 5 | 2008 | 1263 | 0.080 |
Why?
| | Receptors, Chemokine | 1 | 2008 | 44 | 0.080 |
Why?
| | Female | 10 | 2022 | 59520 | 0.080 |
Why?
| | Heart Rate | 4 | 2007 | 709 | 0.080 |
Why?
| | Histones | 1 | 2013 | 535 | 0.080 |
Why?
| | Indoles | 2 | 2014 | 304 | 0.070 |
Why?
| | Glomerular Mesangium | 1 | 2007 | 17 | 0.070 |
Why?
| | Stroke Volume | 3 | 2014 | 504 | 0.070 |
Why?
| | Random Allocation | 2 | 2008 | 335 | 0.070 |
Why?
| | Arginine Vasopressin | 1 | 2007 | 46 | 0.070 |
Why?
| | Substance P | 1 | 2007 | 44 | 0.070 |
Why?
| | Heart Function Tests | 2 | 2004 | 58 | 0.070 |
Why?
| | Sulfonamides | 1 | 2010 | 445 | 0.070 |
Why?
| | Chronic Disease | 2 | 2004 | 1578 | 0.070 |
Why?
| | Time Factors | 5 | 2014 | 6116 | 0.070 |
Why?
| | Case-Control Studies | 3 | 2021 | 3003 | 0.070 |
Why?
| | Heart Rupture | 2 | 2004 | 4 | 0.070 |
Why?
| | Azepines | 2 | 2019 | 75 | 0.070 |
Why?
| | Castration | 1 | 2005 | 14 | 0.070 |
Why?
| | Obesity | 1 | 2018 | 2508 | 0.070 |
Why?
| | Ventricular Function, Left | 2 | 2014 | 467 | 0.060 |
Why?
| | Hydroxamic Acids | 2 | 2018 | 80 | 0.060 |
Why?
| | Reactive Oxygen Species | 1 | 2008 | 531 | 0.060 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2017 | 270 | 0.060 |
Why?
| | Rupture | 1 | 2005 | 96 | 0.060 |
Why?
| | Triazoles | 2 | 2019 | 131 | 0.060 |
Why?
| | Gene Expression | 1 | 2010 | 1421 | 0.060 |
Why?
| | Muscle, Skeletal | 1 | 2014 | 1473 | 0.060 |
Why?
| | Epigenesis, Genetic | 2 | 2019 | 521 | 0.060 |
Why?
| | Hydroxyproline | 1 | 2004 | 22 | 0.060 |
Why?
| | Thiazolidines | 1 | 2004 | 7 | 0.060 |
Why?
| | Neutrophil Infiltration | 1 | 2004 | 96 | 0.060 |
Why?
| | Heart Rupture, Post-Infarction | 1 | 2004 | 3 | 0.060 |
Why?
| | Growth Inhibitors | 1 | 2004 | 43 | 0.060 |
Why?
| | Humans | 12 | 2022 | 114699 | 0.060 |
Why?
| | Dipeptides | 1 | 2004 | 48 | 0.060 |
Why?
| | Models, Biological | 2 | 2013 | 1621 | 0.060 |
Why?
| | Proline | 1 | 2004 | 72 | 0.060 |
Why?
| | Thiazoles | 1 | 2004 | 110 | 0.050 |
Why?
| | Glomerular Filtration Rate | 2 | 2022 | 604 | 0.050 |
Why?
| | Nitriles | 1 | 2004 | 149 | 0.050 |
Why?
| | Organ Specificity | 1 | 2004 | 268 | 0.050 |
Why?
| | Nephrectomy | 1 | 2004 | 150 | 0.050 |
Why?
| | Orchiectomy | 1 | 2003 | 57 | 0.050 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2022 | 146 | 0.050 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2022 | 153 | 0.050 |
Why?
| | Acute Disease | 1 | 2004 | 911 | 0.050 |
Why?
| | Survival Rate | 1 | 2005 | 1644 | 0.050 |
Why?
| | Elastic Modulus | 1 | 2022 | 116 | 0.050 |
Why?
| | Receptors, Bradykinin | 1 | 2001 | 4 | 0.050 |
Why?
| | Microscopy, Atomic Force | 1 | 2022 | 113 | 0.050 |
Why?
| | Protein Binding | 2 | 2019 | 1890 | 0.050 |
Why?
| | Cytoprotection | 1 | 2001 | 51 | 0.050 |
Why?
| | Protein Isoforms | 2 | 2013 | 338 | 0.050 |
Why?
| | Transforming Growth Factor beta | 2 | 2019 | 448 | 0.050 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2001 | 76 | 0.050 |
Why?
| | Vasoconstrictor Agents | 1 | 2021 | 113 | 0.040 |
Why?
| | Interleukin-10 | 1 | 2022 | 299 | 0.040 |
Why?
| | Body Weight | 1 | 2004 | 869 | 0.040 |
Why?
| | Cardiac Output | 1 | 2000 | 143 | 0.040 |
Why?
| | Sex Characteristics | 1 | 2004 | 641 | 0.040 |
Why?
| | Arrhythmias, Cardiac | 1 | 2022 | 279 | 0.040 |
Why?
| | Polymerase Chain Reaction | 2 | 2013 | 993 | 0.040 |
Why?
| | Organ Size | 1 | 2000 | 436 | 0.040 |
Why?
| | MAP Kinase Signaling System | 1 | 2021 | 276 | 0.040 |
Why?
| | Systole | 2 | 2014 | 171 | 0.040 |
Why?
| | Nitric Oxide | 1 | 2004 | 823 | 0.040 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2019 | 260 | 0.040 |
Why?
| | Cell Adhesion Molecules | 1 | 2019 | 168 | 0.040 |
Why?
| | Adipose Tissue, White | 1 | 2018 | 27 | 0.040 |
Why?
| | Enhancer Elements, Genetic | 1 | 2019 | 151 | 0.040 |
Why?
| | Echocardiography | 1 | 2000 | 553 | 0.040 |
Why?
| | Inflammation | 2 | 2008 | 2480 | 0.040 |
Why?
| | Myosins | 1 | 2018 | 126 | 0.040 |
Why?
| | Signal Transduction | 3 | 2017 | 4515 | 0.040 |
Why?
| | Drug Therapy, Combination | 2 | 2014 | 951 | 0.040 |
Why?
| | Diet, High-Fat | 1 | 2018 | 225 | 0.030 |
Why?
| | RNA Polymerase II | 1 | 2019 | 284 | 0.030 |
Why?
| | Isoenzymes | 1 | 2017 | 283 | 0.030 |
Why?
| | Molecular Imaging | 1 | 2016 | 50 | 0.030 |
Why?
| | Hydrogels | 1 | 2022 | 573 | 0.030 |
Why?
| | Small Molecule Libraries | 1 | 2016 | 79 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2017 | 778 | 0.030 |
Why?
| | Serotonin | 1 | 2016 | 292 | 0.030 |
Why?
| | Ketocholesterols | 1 | 2014 | 8 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2016 | 591 | 0.030 |
Why?
| | Ezetimibe | 1 | 2014 | 24 | 0.030 |
Why?
| | Azetidines | 1 | 2014 | 31 | 0.030 |
Why?
| | Apolipoproteins E | 1 | 2014 | 80 | 0.030 |
Why?
| | Simvastatin | 1 | 2014 | 59 | 0.030 |
Why?
| | Transcriptome | 1 | 2019 | 725 | 0.030 |
Why?
| | Adaptation, Physiological | 1 | 2017 | 483 | 0.030 |
Why?
| | Energy Metabolism | 1 | 2018 | 731 | 0.030 |
Why?
| | Immunoblotting | 1 | 2013 | 283 | 0.030 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2013 | 42 | 0.030 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2013 | 128 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 313 | 0.020 |
Why?
| | Cardiovascular Diseases | 2 | 2014 | 1727 | 0.020 |
Why?
| | Cell Cycle | 1 | 2013 | 542 | 0.020 |
Why?
| | Atherosclerosis | 1 | 2014 | 341 | 0.020 |
Why?
| | Lipids | 1 | 2014 | 580 | 0.020 |
Why?
| | Adenoviridae | 1 | 2011 | 184 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2018 | 1072 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2013 | 1083 | 0.020 |
Why?
| | RNA Interference | 1 | 2011 | 433 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2011 | 535 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2016 | 2765 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2018 | 6347 | 0.020 |
Why?
| | Probability | 1 | 2008 | 289 | 0.020 |
Why?
| | Albuminuria | 1 | 2008 | 164 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2013 | 1701 | 0.020 |
Why?
| | Reference Values | 1 | 2008 | 743 | 0.020 |
Why?
| | Middle Aged | 2 | 2018 | 26738 | 0.020 |
Why?
| | Blotting, Western | 1 | 2008 | 1147 | 0.020 |
Why?
| | Neovascularization, Pathologic | 1 | 2007 | 281 | 0.020 |
Why?
| | NG-Nitroarginine Methyl Ester | 1 | 2004 | 38 | 0.010 |
Why?
| | Lung | 1 | 2016 | 3561 | 0.010 |
Why?
| | Infant | 1 | 2017 | 7964 | 0.010 |
Why?
| | Renal Circulation | 1 | 2004 | 53 | 0.010 |
Why?
| | Connective Tissue Growth Factor | 1 | 2004 | 21 | 0.010 |
Why?
| | Cell Movement | 1 | 2008 | 869 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2008 | 1629 | 0.010 |
Why?
| | Immediate-Early Proteins | 1 | 2004 | 52 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2008 | 1693 | 0.010 |
Why?
| | Kidney Glomerulus | 1 | 2004 | 100 | 0.010 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2004 | 102 | 0.010 |
Why?
| | Nitric Oxide Synthase | 1 | 2004 | 209 | 0.010 |
Why?
| | Mast Cells | 1 | 2004 | 116 | 0.010 |
Why?
| | Rats, Inbred WKY | 1 | 2003 | 32 | 0.010 |
Why?
| | Rats, Inbred SHR | 1 | 2003 | 41 | 0.010 |
Why?
| | Diastole | 1 | 2003 | 130 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2007 | 1950 | 0.010 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2004 | 351 | 0.010 |
Why?
| | Cell Division | 1 | 2004 | 758 | 0.010 |
Why?
| | Receptor, Bradykinin B2 | 1 | 2001 | 2 | 0.010 |
Why?
| | Receptor, Angiotensin, Type 2 | 1 | 2001 | 7 | 0.010 |
Why?
| | Receptor, Angiotensin, Type 1 | 1 | 2001 | 20 | 0.010 |
Why?
| | Monocytes | 1 | 2004 | 504 | 0.010 |
Why?
| | Mice, Inbred Strains | 1 | 2001 | 396 | 0.010 |
Why?
| | Aged | 1 | 2018 | 19074 | 0.010 |
Why?
| | Adolescent | 1 | 2017 | 17853 | 0.010 |
Why?
| | Neutrophils | 1 | 2004 | 1176 | 0.010 |
Why?
| | Child | 1 | 2017 | 18420 | 0.010 |
Why?
| | DNA | 1 | 2004 | 1352 | 0.010 |
Why?
| | Adult | 1 | 2018 | 30553 | 0.010 |
Why?
| | Disease Progression | 1 | 2001 | 2380 | 0.010 |
Why?
| | Biomarkers | 1 | 2004 | 3408 | 0.010 |
Why?
|
|
Cavasin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|